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Available online 11 September 2008Background: Profilin is a panallergen found in pollens and fruits. Sensitization to this
protein may explain some sensitization to multiple pollen species. We aimed to evaluate
sensitization to profilin in patients suffering from respiratory allergy sensitized to pollens,
in the Central region of Portugal.
Methods: Patients were evaluated for asthma symptoms, rhinitis, conjunctivitis and food
allergy. Skin prick tests (SPT) to aeroallergens including 12 different pollens and profilin
(nPho d 2) were performed. The patients were divided into two study groups according to the
region of residence: A — inland region and B — coastal region.
Results: A total of 370 patients were evaluated (277-group A; 93-group B). 65.9% showed
positive skin prick tests and 76.2% were positive to pollens (87.1%-group A; 42.85%-group
B; pb0.0001). All the patients sensitized to pollens had rhinitis (p=0.001). Sensitization to
profilin was associated with pollen sensitization (p=0.014). 43 patients were sensitized to
profilin (40-group A; 3-group B; p=0.006). 21.0% of patients sensitized to pollens, were also
sensitized to profilin. 39 patients were sensitized to at least two pollens (pb0.0001). Four
profilin and pollen sensitized patients had oral allergy syndrome complaints to melon. This
syndrome was related with profilin sensitization (p=0.001).
Conclusions: It is advisable to perform SPT to profilin, particularly in the Inland region, for a
better differential diagnosis between cross-reactivity and true sensitization to pollens. The
results together with the medical history may support the choice for a specific
immunotherapy option.






The high allergen exposure namely to pollens, is one of the
pointed factors that has been linked with the increase in
prevalence of allergic diseases such as asthma, and rhino-
conjunctivitis (Jarvis and Burney, 1998; Taylor et al., 2007;
Gilmour et al., 2006). Climate changes result in an increase of
the allergen burden, a fact that combined with pollutant
exposures, can act synergistically to enhance the allergicgologia, Hospitais da Uni
.pt, tavares.beatriz@gmail
er B.V. All rights reservedresponse, and increase respiratory symptoms (Gilmour et al.,
2006; D'Amato et al., 2007a,b; Beggs, 2004). The patterns of
sensitization to pollens depend on exposure and differ
according to region, since the climate, geography, and
vegetation diverge (D'Amato et al., 2007a,b).
A study of aeroallergen sensitization in different regions of
Portugal evaluated by skin prick tests (SPT), showed a higher
level of sensitization to pollens, particularly to grasses and
Parietaria, in the Central region compared with the otherversidade de Coimbra, Apartado 9057, 3001-301 Coimbra, Portugal.
.com (B. Tavares).
.
Fig. 1 –Location of the Centres where the study was
performed.
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particular relevance in the Inland Central region of the country
(Loureiro et al., 2005).
Several studies report a high prevalence of sensitization to
different pollen species belonging to taxonomically distant
families (Valenta et al., 1992; Mari, 2001). This can be explained
by sensitization to panallergens present in pollens, namely
profilins and calcium-binding proteins (Valenta et al., 1991,
1992, 1998; Radauer et al., 2006; Ebner et al., 1995).
Profilins are small actin-binding proteins of 12–15 kDa in
size (Thorn et al., 1997; Witke, 2004). They have been well
preserved during evolution, namely the protein folds, and can
be found in all eukaryotic cells. They are essential in all
organisms since they regulate the dynamics of actin poly-
merization, for in vivo motility, and function as hubs that
control a complex network of molecular interactions (Witke,
2004). The plant derived class of profilins show a high
sequence homology (50 to 80%) (Radauer et al., 2006; Thorn
et al., 1997). Profilin was first reported as a minor allergen in
birch pollen (Valenta et al., 1991).
Profilins from pollen and plant foods, are highly cross-
reactive and elicit IgE responses in 10–30% of pollen-allergic
patients (Valenta et al., 1992; Asero et al., 2008). They may be
responsible for several pollen-food allergy syndromes (Egger
et al., 2006). The identification and purification of such a
panallergen for diagnostic purposes, allowed the understand-
ing of several clinical observations with consequential ther-
apeutic implications.
The aim of this study was to evaluate sensitization to
profilin in patients suffering from respiratory allergy, sensi-
tized to pollens, in the Central region of Portugal (Inland and
Coastal regions).2. Methods
2.1. Patients
The study was carried out in five Allergy Medical Centres
located in the Central region of Portugal, in the cities of
Covilhã and Oliveira do Hospital (Inland region); Leiria, Fátima
and Entroncamento (Coastal region) (Fig. 1).
The study was performed with the consent of the patients
or their representatives.
We assessed all consecutive patients observed for the first
time for allergic respiratory symptoms, during a three-month
period (from the beginning of February to the end of April). They
were evaluated for asthma symptoms, rhinitis, conjunctivitis
and food allergy including oral allergy syndrome (Ortolani et al.,
1988), bymeans ofmedical history. Skin prick testswere carried
out in all the patients that met inclusion criteria.
Exceptions included pregnant women, patients that were
previously submitted to specific immunotherapy and patients
that had some contra-indication for the performance of skin
prick tests.
2.2. Skin prick tests
The patients studied were submitted to skin prick tests (SPT)
with commercial standardized extracts of aeroallergens, withknown potency, including house dust mites, cat and dog
dander, moulds, twelve different pollen species representative
of the corresponding botanical family, and reflecting the most
important range of known allergenicity and exposure levels of
the regions, and profilin from Phoenix dactilyfera (date palm)
pollen (Pho d 2, 50 μg/ml) (ALKAbelló, Madrid, Spain). We used
for skin testing in all the study centres the same extracts,
including the pollen extracts. Histamine hydrochloride
(10 mg/ml) and saline were used as positive and negative
controls respectively. The tests were performed and inter-
preted according to the European Academy of Allergology and
Clinical Immunology recommendations (Dreborg, 1989). Lan-
cets with 1 mm were used for skin pricking (ALKAbelló,
Madrid, Spain). The mean of the longest and the midpoint
orthogonal diameters (mean diameter) of wheal size were
considered for analysis, and a wheal diameter ≥3 mm greater
than that induced by the negative control was regarded as
positive.
The tests were performed by one investigator in the Covilhã
Centre and by another researcher in all the other Centres.
2.3. Statistical analysis
Statistical analysis was performed with SPSS 15.0 (2006 SPSS
Inc, Chicago, Ill, USA). Frequency distribution was obtained for
the different qualitative variables. Average and Standard
Deviation (SD) were calculated, for quantitative variables.
Patients were divided into two study groups according to the
region of residence: group A — inland region; and group B —
coastal region. Sub-groups were defined according to positive
results in SPT and at least one pollen sensitization. Differences
between the two groups were analysed by means of χ2 tests
Fig. 2 –Organogram of distribution of patients by groups A
and B.









Patients 186/76.2 162/87.1 24/12.9 b0.0001
Profilin 39/21.0 36/22.2 3/12.5 0.275
Platanus acerifolia 60/32.3 57/35.2 3/12.5 0.027
Betula verrucosa 58/31.7 57/35.2 1/4.8 0.005
Olea europaea 88/47.3 81/50.0 7/29.2 0.056
Quercus robur 43/23.5 39/24.2 4/18.2 0.531
Robinia pseudoacacia 56/31.1 53/33.3 3/14.3 0.076
Tilia cordata 49/27.1 47/29.6 2/9.1 0.043
Pinus sylvestris 53/29.4 53/33.3 0/0.0 0.002
Grasses⁎ 134/72.0 113/69.8 21/87.5 0.071
Parietaria judaica 80/43.0 68/42.0 12/50.0 0.459
Artemisia vulgaris 73/39.2 65/40.1 8/33.3 0.525
Plantago lanceolata 107/57.5 94/58.0 13/54.2 0.721
Chenopodium album 73/39.2 60/37.0 13/54.2 0.109
⁎Grasses mixture included: Dactylis glomerata, Festuca pratensis,
Lolium perenne, Phleum pratense and Poa pratensis extracts.
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qualitative and quantitative variables respectively. Sensitiza-
tion to profilin and pollens was evaluated by χ2 tests. We
considered three groups of patients sensitized to pollens for
analysis: those with sensitization to more than one pollen,
those sensitized to at least six pollens and those mono-
sensitized to grasses. Significancewas considered for a p value
less than 0.05.3. Results
3.1. Overall analysis
A total of 370 patients were evaluated, 277 in group A and 93 in
group B. The average age was 27.08±17.49 years old (group A
25.27±16.68 and group B 32.46±18.80; p=0.0001). 62.2% were
female (group A 59.2% and group B 71.0%; p=0.004).
The distribution of asthma, rhinitis and conjunctivitis was
53.4/47.3, 53.8/90.3 and 8.7/20.4% in groups A versus B


























Asthma (total) 101/54.3 90 / 55.6 11/45.8 0.372
Rhinitis (total) 134/72.0 110 / 67.9 24/100.0 0.001
Conjunctivitis (total) 28/15.1 22 / 13.6 6/25.0 0.144
Rhino-conjunctivitis 23 / 12.4 20 / 12.3 3 / 12.5 0.598
Asthma and rhinitis 68 / 36.6 60 / 37.0 8 / 33.3 0.725
Asthma and rhino-
conjunctivitis
4 / 2.2 1 / 0.6 3 / 12.5 0.007
Food allergy (OAS) 4/2.2 3/1.9 1/4.2 0.466
Age is shown as average and SD. OAS — oral allergy syndrome.A total of 244 (65.9%) patients showed positive skin prick
tests (188/277–67.9% in group A and 56/93–60.2% in group B) in
which 186 (76.2%) were positive to pollens (162/186–87.1% in
group A and 24/56–42.85% in group B). The prevalence of
sensitization to profilin was 11.62%. Fig. 2, shows the
distribution organogram of patients according to the several
groups.
3.2. Patients sensitized to pollens
Demographic and clinical data of the patients sensitized to
pollens are shown in Table 1. Patients from group Aweremore
frequently sensitized to pollens than that from group B
(pb0.0001).
Analysis of pollen positive SPT, showed that all the group B
patients that had positive SPT to pollens suffered from rhinitis
(p=0.001). We could not observe any difference regarding
asthma and conjunctivitis distribution, nor combined diagnosisTable 3 – SPT wheal diameters of patients with pollen
positive SPT (average±SD)
Pollen positive SPT
Total Group A Group B p
Histamine 5.73±2.19 5.96±2.22 4.13±0.90 b0.0001
Platanus acerifolia 4.15±1.78 4.18±1.82 3.67±0.57 0.898
Betula verrucosa 4.33±2.26 4.33±2.28 4.0 0.793
Olea europaea 5.01±2.36 4.93±2.29 6.00±3.05 0.342
Quercus robur 4.05±2.17 4.08±2.24 3.75±1.50 0.825
Robinia pseudoacacia 3.55±1.27 3.51±1.05 4.33±2.31 0.731
Tilia cordata 3.88±1.34 3.87±1.36 4.00±1.41 0.823
Pinus sylvestris 3.79±1.50 3.79±1.50 – –
Grasses 6.57±3.26 6.66±3.47 6.10±1.81 0.983
Parietaria judaica 5.30±2.84 5.49±3.01 4.25±1.14 0.538
Artemisia vulgaris 4.07±1.64 4.02±1.59 4.50±2.07 0.429
Plantago lanceolata 5.19±3.26 5.35±3.44 4.00±0.82 0.627
Chenopodium album 4.32±2.24 4.45±2.43 3.69±0.86 0.652
Profilin 4.23±1.57 4.15±1.51 5.33±2.30 0.218




Platanus acerifolia 25/64.1 b0.0001
Betula verrucosa 22/56.4 b0.0001
Olea europaea 30/76.9 b0.0001
Quercus robur 21/53.8 b0.0001
Robinia pseudoacacia 23/59.0 b0.0001
Tilia cordata 22/56.4 b0.0001
Pinus sylvestris 15/38.5 0.163
grasses 37/94.9 b0.0001
Parietaria judaica 25/64.1 0.003
Artemisia vulgaris 29/74.4 b0.0001
Plantago lanceolata 29/74.4 0.017
Chenopodium album 24/61.5 0.001
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differences were only for those with asthma and rhino-
conjunctivitis.
Four patients had oral allergy syndrome (OAS) complaints,
related with the ingestion of melon and one patient also with
the ingestion of apple, peach and plum.
Analysis of pollen positive SPT, showed that sensitization
was significantly higher in group A to Platanus acerifolia,
B. verrucosa, Tilia cordata and Pinus sylvestris. There were no
significant differences between the two regions for the other
pollens and profilin.
Table 2 shows thedistribution of positive SPT to thedifferent
pollens and profilin.
For each pollen extract tested skin reactivity was similar in
both groups.
Compared to the other pollens, the largest SPT average
wheal diameterwas to grasses pollen extract. Table 3 shows the
SPT average wheal diameters to histamine, to the different
pollens and profilin. Table 4 shows sensitization to profilin in
patients with pollen positive SPT.
Forty three patientswere sensitized to profilin. In the group
of patients sensitized to pollens, 36 patients were observed in
group A and only 3 in group B. Four patients (from group A)
were not sensitized to any tested pollen extract. Two patients
with perennial rhinitis were sensitized to mites andmites and
dog respectively, and the other two patients (one with rhinitisFig. 3 –Sensitization to pollens andprofilin. PolyN1 pollen— sensit
to at least 6 pollens; mono grasses—mono-sensitization to grasseand the other with asthma) were SPT negative for the other
allergenic extracts.
38.7% of patients were sensitized to at least half of the
pollens tested and 78.5% were sensitized to at least two
pollens. 7.5% of patients were mono-sensitized to grasses
whereas 65.1% were sensitized to grasses and other pollens.
All the 39 patients sensitized to profilin and pollens, were
sensitized to at least two pollens (pb0.0001) (one of them was
always grasses; p=0.012), and 31 of them were sensitized to at
least half of the pollens tested (pb0.0001) (Fig. 3).
Profilin sensitization was associated to male gender
(p=0.034) and oral allergy syndrome (p=0.001). Association
with asthma diagnosis, rhinitis or conjunctivitis was not found.4. Discussion
This study was performed in two different regions of the
Central region of Portugal. The Inland region has a mountai-
nous topography, with a peak 2 km above the sea level. It has a
continental climate, with cold winters and hot summers. The
flora found in these zones varies from base to top of the
mountains. The forest is frequent at lower altitudes and
vegetation rich in weeds, grasses and shrubs is more frequent
at the top. These conditions lead to high pollen counts in
spring. The Coastal region is plain by the sea and rocky when
one goes inland. It has a temperate climate with Atlantic
influence. The soils are fertile for agriculture so, cultivated
areas alternate with woodlands and forests. The pollen sea-
son is not as intense as in the Inland region (Instituto de
Meteorologia. Portugal, 2008; SPAIC/Schering-Plough/CIPA,
1999).
In this study, we aimed to evaluate the sensitization to
profilin in two groups of patients suffering from respiratory
allergy, one from the Inland region and the other from the
Coastal region, and the relationship with pollen sensitization
and food allergy. This was the first study that assessed
sensitization to profilin in Portugal.
All the patients had symptoms of asthma and/or rhinitis
and/or conjunctivitis and were enquired for food allergy
complaints, namely oral allergy syndrome (Ortolani et al.,
1988).
Skin prick tests were carried out with a series of aeroaller-
gens representative of the regions. Additionally, patients wereization tomore thanonepollen; poly N6 pollens— sensitization
s.
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(Pho d 2). Pho d 2 is an important allergen as it is responsible
for more than 70% of the IgE reactivity to the pollen extract. It
has high sequence identity with other allergenic food and
pollen profilins (Asturias et al., 2005; Kwaasi et al., 2002).
The large extent of cross-reactivity among plant profilins
justifies using a single profilin for diagnosis. However, the fine
specificity of IgE directed to variable epitopes may influence
the clinical manifestation of profilin sensitization (Radauer
et al., 2006). Natural profilin seems to be better for diagnosis
than its recombinant counterpart both in vitro and in vivo,
possibly because of improper folding of the recombinant
molecule, as shown for rBet v 2 and nBet v 2 (van Ree et al.,
1999; Pauli et al., 1996; Elfman et al., 1997;Wensing et al., 2002).
Performing SPT allowed the reactivity to carbohydrate
determinants to be excluded, antigenic structures that have
poor functional activity, but are responsible for a wide pattern
of in vitro cross-reactivity among molecules with unrelated
protein sequence (Mari, 2001; Aalberse and van Ree, 1997; Mari
et al., 1999; van der Veen et al., 1997). Additionally, SPT have
shown a high sensitivity but a low specificity for allergy
diagnosis of asthma and rhinitis (Dreborg, 1989; Brand et al.,
1993; Witteman et al., 1996; Bousquet et al., 2008).
Since the tests were performed by only two investigators,
the variability upon investigator was reduced providing
reliability to the tests results (Dreborg, 1989).
A total of 65.9% of patients showed positive SPT. Patients
fromthe Inland region groupwere significantlymore frequently
sensitized topollens than that fromCoastal regiongroup. This is
probably related to the higher pollen counts found in the Inland
region (SPAIC/Schering-Plough/CIPA, 1999), which may cause
higher levels of allergic sensitization in the people exposed
(Jarvis and Burney, 1998; Taylor et al., 2007).
The sample was homogenous for age and gender, con-
sidering the sub-groups of patients sensitized to pollens.
Despite the greater number of patients sensitized to
pollens in group A, the magnitude of the elicited wheals is
not greater compared with that of group B. Grass pollen
extract elicited the largest SPT average wheal diameter in both
groups.
The prevalence of sensitization to profilin in the whole
sample was 11.62%. Sensitization to profilin was 21.0% of all
pollen sensitized individuals. This percentage is similar to
that observed by Valenta et al. (1992) in their first report of
profilin as a plant panallergen (20%) and by Pauli et al. (1996)
using rBetv2 for SPT (19.6%). However Asero et al. (2008) found
a higher proportion of sensitization to date palm profilin (30%)
in patients sensitized to pollens. In our study, sensitization to
profilin in pollen sensitized patients from the Coastal region
(12.5%) comparedwith that from the Inland region (22.2%) was
even lower. These differences might be due to geographical
factors.
We found that sensitization to profilin was associated with
pollen sensitization as expected. However, 4 patients were
sensitized to profilinwithout sensitization to the pollens tested.
This was a bizarre finding. One can wonder if those were false
positives or the patients could be sensitized to other pollens not
tested in this study. However, we could confirm the results of
SPT in one patient (tested negative except for profilin), by
repeating the study 11 months after the first evaluation.Almost all the patients sensitized to profilin lived in the
Inland region where the sensitization to pollens is more
frequent.
38.7% of patients were sensitized to at least half of the
pollens tested and 78.5%were sensitized to at least two pollens.
Most of the patients sensitized to grasses were also
sensitized to other pollens (65.1%) whereas only 7.5% of
patients were mono-sensitized to grasses.
All the 39 patients sensitized to profilins and pollens, were
sensitized to at least two pollens and 31 of them were
sensitized to at least half of the pollens tested. Mari (2001)
has shown, at the molecular level that 55% of patients with
multiple pollen sensitizations had IgE to rBet v 2, the
recombinant profilin of Betula verrucosa.
In our patients, the diagnosis wasmade only by SPT, butwe
could find that 43% of patients that were sensitized to more
than five pollens were also sensitized to profilin. This slightly
lower percentage might be due to differences in the fine
specificity of IgE directed to variable epitopes of profilin
(Radauer et al., 2006) in our population. This might lead to
deficient recognition of profilin from other pollens, compared
with patients from other countries.
When we considered the percentage of patients sensitized
to more than one pollen, the percentage of sensitization to
profilin decreased to 26.7%. These findings agree with the
current understanding of profilin as a plant panallergen
(Valenta et al., 1992; Radauer et al., 2006; Ebner et al., 1995).
The higher average wheal diameter results of SPT to
grasses lead us to explore if sensitization to grasses was
negatively related to sensitization to profilin. We could find
that mono-sensitization to grasses was not associated with
sensitization to profilin, as expected.
A positive association between sensitization to profilin and
male gender was found. A possible explanation for this is that
a gene or genes responsible for a predisposition to sensitiza-
tion to profilin can better express their phenotype in males.
From the 43 patients that showed to be sensitized to
profilin, only 4 patients had oral allergy syndrome to fruit
ingestion namely melon, a clinical manifestation classically
described to be associated with sensitization to profilin
(Wensing et al., 2002; Asero et al., 2003). As Wensing et al.
(2002) showed, in analogy to IgE to carbohydrate determi-
nants, cross-reactive IgE against food profilins have no or very
limited clinical relevance. Recently Asero et al. (2008) found
that 57% of patients sensitized to profilin had food allergy.
Differences between these studies might be due to different
patterns of sensitization in the study populations.
The study of sensitization to profilin is of crucial impor-
tance for diagnosis in patients with multiple pollen sensitiza-
tion (Valenta et al., 1992; Mari, 2001). The diagnosis based on
serologic specific IgE determination is presently impossible in
normal clinical settings. The use of a profilin extract for SPT
can surpass this impracticality.5. Conclusion
We can conclude that SPT with profilin, particularly in the
Inland region, might help to differentiate between cross-
reactivity phenomena and true sensitization to pollens.
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sensitization to the different pollens or cross-reactivity by
sensitization to other pan-allergen. If the SPT to profilin is
positive in a patient poly-sensitized to pollens it is advisable to
account the relevant pollens according to medical history.
Therefore, the results may support the choice for a specific
immunotherapy option as well as to improve the extract
selection for treatment.R E F E R E N C E S
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